DES Minus the Stent: Paclitaxel-Coated Balloon Suppresses In-Stent Restenosis in Small Pilot Study
15th Nov 2006, 02:07 GMT
The strategy avoids some of the limitations of contemporary drug-eluting stent procedures and could have important interventional roles to play if its early potential is borne out in larger future trials. Heartwire Steve Stiles
DES Minus the Stent: Paclitaxel-Coated Balloon Suppresses In-Stent Restenosis in Small Pilot Study related news:
- AHA: When Stents Fail, Send in the Drug-Coated Balloons — MedPage Today.com Latest Headlines
- Study may boost bare-metal stents — Boston Globe -- Business News
- Study Casts Doubt on Stent Use — WSJ.com: What's News US
- Study Favors TAXUS Stent Over Cypher Stent and Bare-Metal Stents in Diabetic Patients — Nephrology/ Dialysis News from StratCenter.com
- Study May Deal Setback to Stent Use — WSJ.com: What's News US
- Study: balloons better for heart than stents — Health
- Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients — PR Newswire: All Releases
- Boston Scientific shares fall on study — Boston.com / News
- Study: Opening arteries days after heart attack may not help — KLTV - National News
- Nab-Paclitaxel and Carboplatin Appear Effective in Lung Cancer — Medscape Hematology-Oncology Headlines
Latest news from Medscape Headlines:
- New Treatment for Ischemic Stroke on the Horizon
- Adding Bevacizumab to First-Line Lung Cancer Therapy Shows Potential
- Type 1 and 2 T Helper Cell-mediated Colitis
- Radiation Therapy for Chronic Vesicular Hand Dermatitis
- November 14, 2006: In the News
- Alcoholic Liver Disease-Pathophysiological Aspects and Risk Factors
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet
- Bleeding-Edge Benefits
- End-Stage Renal Disease and Drug-Eluting Stents: One Small Step Forward?
- November 13, 2006: In the News